News

Oncologists and scientists warn that extensive cuts to mRNA funding will have devastating impacts on cancer vaccine ...
ACOG released updated clinical guidance on vaccination for COVID-19, respiratory syncytial virus and influenza during ...
June 26 (UPI) -- Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices.
A group of outside advisers to the US Centers for Disease Control and Prevention voted to recommend use of a new Merck shot that can protect babies from respiratory syncytial virus.
CDC advisers recommend Merck's Enflonsia to protect babies from RSV, addressing the leading cause of infant hospitalization ...
One vaccine, Pfizer’s Abrysvo, is available for pregnant women and can pass RSV protection over to newborns. As a result, parents of young children largely rely on antibody drugs that can ...
New CDC vaccine advisers vote to recommend Merck RSV antibody protection for babies Updated: 10:41 AM EDT Jun 26, 2025 Editorial Standards ⓘ By Meg Tirrell, CNN ...
However, ACIP recommendations are tremendously influential in how vaccines are used in the US, with implications for insurance coverage and state policies. Advisers endorse Merck RSV antibody ...
A group of outside advisers to the US Centers for Disease Control and Prevention voted to recommend use of a new Merck shot that can protect babies from respiratory syncytial virus.